Daclatasvir CAS:1009119-64-5

Daclatasvir   CAS:1009119-64-5
Product Details

Product Information

CAS NO.1009119-64-5 10.png
Product NameDaclatasvir
Molecular Weight738.88
Spec / Purity98%min
Supply Capacity
DetailsDaclatasvir is a drug for the treatment of hepatitis C (HCV). It was approved in Europe on 22 August 2014. Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA.Daclatasvir has been tested in combination regimens with pegylated interferon and ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.

If you are going to consult the information about daclatasvir cas:1009119-64-5 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.